Skip to main content
Fig. 3 | Proteome Science

Fig. 3

From: Serum proteomic identification and validation of two novel atherosclerotic aortic aneurysm biomarkers, profilin 1 and complement factor D

Fig. 3

PFN1 and CFD levels in unfractionated serum samples of patients with TAA and HC subjects. A Western blot analysis of PFN1 and CFD in four individual serum samples without pre-treatment from patients with TAA and those from HC subjects. B, C The histograms indicate quantitated band intensity data of (B) PFN1 and (C) CFD in the serum samples of patients with TAA and HC subjects. HC subjects, No. 1–4; TAA patients, No. 5–8. Significant differences were observed between the TAA and HC groups. Images of entire western blots of PFN1 and CFD are shown in Additional File 8

Back to article page

Proteome Science

ISSN: 1477-5956